A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.

The use of biologics in psoriasis and psoriatic arthritis management is not linked to the risk of cardiovascular or venous thromboembolic events.

Dallas Goedert details how the team's victory in Super Bowl LIX is even "more sweet" considering what the Eagles went through ...

Yahoo Sports’ Caroline Fenton spoke with the Philadelphia Eagles tight end about the team’s championship win, his quarterback ...

Urea is an organic compound that touts impressive skin health benefits, particularly when it comes to hydration and ...

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

Not everyone responds to statins, the standard treatment for people at risk of cardiovascular disease, so an alternative ...

Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic ...

Jeffrey Stark, MD, vice president and head of medical immunology at UCB, discusses tailored dosing of bimekizumab-bkzx (Bimzelx) for various inflammatory conditions, highlighting its 5 FDA approvals ...

Managing psoriasis and psoriatic arthritis during the summer involves staying cool, using gentle skin care, and knowing what ...

President Trump’s first term was bad,” he said, “but nobody knows what’s coming. … This is truly nationalism at its worst, because he won on the campaign [largely] to protect American jobs, claiming ...